FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/05/066978 [Registered on: 08/05/2024] Trial Registered Prospectively
Last Modified On: 28/04/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Evaluate The Effect Of Dashmooladi Kwath And Kalyanaka Kshara With Dashmooladi Kwath After Yog Basti In Patients Having Vatashtheela(Benign Prostatic Hyperplasia) 
Scientific Title of Study   A Comparative Clinical Study To Evaluate The Efficacy Of Dashmooladi Kwath And Kalyanaka Kshara With Dashmooladi Kwath After Yog Basti In The Managment Of Vatashtheela (Benign Prostatic Hyperplasia) 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr.Rupesh Gangurde 
Designation  Pg Scholar 
Affiliation  All India Institute Of Ayurveda,New Delhi 
Address  Department Of Kayachikitsa,6 Th Floor,Academic Block,Block C,All India Institute Of Ayurveda,Sarita Vihar,New Delhi

South
DELHI
110076
India 
Phone  9637301931  
Fax    
Email  rupeshgangurde13@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr.Jonah S 
Designation  Professor and Head Of Department,Department Of Kayachikitsa 
Affiliation  All India Institute Of Ayurveda,New Delhi 
Address  Department Of Kayachikitsa,6 Th Floor,Academic Block,Block C,All India Institute Of Ayurveda,Sarita Vihar,New Delhi

South
DELHI
110076
India 
Phone  8589805246  
Fax    
Email  jonahdr@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr.Rupesh Gangurde 
Designation  Pg Scholar 
Affiliation  All India Institute Of Ayurveda,New Delhi 
Address  Department Of Kayachikitsa,6 Th Floor,Academic Block,Block C,All India Institute Of Ayurveda,Sarita Vihar,New Delhi

South
DELHI
110076
India 
Phone  9637301931  
Fax    
Email  rupeshgangurde13@gmail.com  
 
Source of Monetary or Material Support  
All India Institute Of Ayurveda,New Delhi 
 
Primary Sponsor  
Name  All India Institute Of AyurvedaNew Delhi 
Address  All India Institute Of Ayurveda,Mathura Road,Gautam Puri,Sarita Vihar,New Delhi-110076 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DR RUPESH GANGURDE  ALL INDIA INSTITUTE OF AYURVEDA,NEW DELHI  OPD OF KAYACHIKITSA DEPARTMENT,ALL INDIA INSTITUTE OF AYURVDA,GAUTAM PURI,SARITA VIHAR,NEW DELHI-110076
South
DELHI 
9637301931

rupeshgangurde13@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee,All India Institute Of Ayurveda,New Delhi  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:N401||Benign prostatic hyperplasia withlower urinary tract symptoms. Ayurveda Condition: VATASHTHILA,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmProcedure-yoga-bastiH, योग-बस्तिः (Procedure Reference: CHARAKA SAMHITA, Procedure details: BALA TAIL 80 ML ANUVASANA BASTI FOR 5 DAYS AND ERANDMOOLADI NIRUHA BASTI 500 ML FOR 3 DAYS IN YOGA BASTI KRAMA)
(1) Medicine Name: BALA TAIL, Reference: ASHTANG HRIDAYA, Route: Rectal, Dosage Form: Taila, Dose: 80(ml), Frequency: od, Duration: 5 Days
(2) Medicine Name: ERANDMOOLADI NIRUHA, Reference: ASHTANG HRIDAYA, Route: Rectal, Dosage Form: Kwatha/Kashaya, Dose: 500(ml), Frequency: od, Duration: 3 Days
2Comparator ArmDrugClassical(1) Medicine Name: DASHMOOLADI KWATH, Reference: BHAISHAJYARATNAWALI, Route: Oral, Dosage Form: Kwatha/ Kashaya, Dose: 100(ml), Frequency: bd, Bhaishajya Kal: Pragbhakta, Duration: 42 Days, anupAna/sahapAna: No, Additional Information: -
(2) Medicine Name: KALYANAKA KSHARA, Reference: ASHTANG HRIDAYA, Route: Oral, Dosage Form: Kshara , Dose: 500(mg), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 42 Days, anupAna/sahapAna: Yes(details: DASHMOOLADI KWATHA 100 ML), Additional Information: -
 
Inclusion Criteria  
Age From  40.00 Year(s)
Age To  70.00 Year(s)
Gender  Male 
Details  1 Male Patients Having Age Between 40 TO 70 Years. 2 Patients Having Signs And Symptoms Of Vatashtheela(Bph). 3 Patients Diagnosed With Grade 1 2 Or 3.
4 Patients Having Psa Less Than Or Equal To 4. 5 Patients Fit For Niruha And Anuvasana Basti. 
 
ExclusionCriteria 
Details  1 Patients Having Age Below 40 And Above 70.
2 Patients Diagnosed With Bph Grade 4.
3 Patients Having Psa Greater Than 4.
4 Patients With Malignancies And Congetinal Deformities Of Urogenital Tract.
5 Patients With Umcontrolled Diabetes And Hypertension.
6 Patients Unfit For Niruha And Anuvasana Basti. 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Improvement In Incomplete Emptying,Frequency,Intermittency,Urgency,Weak Stream,Straining,Nocturia In Patients Of Vatashtheela (BPH).  Day 0,1 Week And 6 Weeks 
 
Secondary Outcome  
Outcome  TimePoints 
1.Improvement In Quality Of Life Assesed With The Help Of International Prostate Symptom Score.
2.Changes In Post Voidal Residual Volume Of Urine And Prostate Size On Ultrasound. 
DAY 0,1 WEEK AND 6 WEEKS 
 
Target Sample Size   Total Sample Size="66"
Sample Size from India="66" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   15/05/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

A. Primary Objectives

To evaluate the efficacy of Dadhmooladi Kwath and Kalyanaka Kshara with Dashmooladi kwath after Yog Basti in the management of Vatashtheela (BPH) in patients having age between 40 to 70 years by estimating the level of IPSS-International Prostate Symptom Score (created by American Urology Association).

B. Secondary Objectives

·       To determine the improvement in IPSS-International Prostate Symptom Score (AUA) in patients of Vatashtheela (BPH).

·       To evaluate reduction in Prostate Size.

·       To evaluate reduction in Prostate weight.

·       To validate a Module designed for management of Vatashtheela (BPH).

 
Close